What is the analyst consensus rating for AXSM?

The analyst consensus rating for AXSM is "Buy" based on 25 analyst recommendations.

What is the average price target for AXSM?

The average 12-month price target for AXSM is $212.29, representing an upside of 26.0% from the current price of $168.50.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.

Axsome Therapeutics, Inc. (AXSM) Forecast: Analyst Ratings & Targets

Latest AXSM Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Mar 25, 2026	Yatin Suneja	Guggenheim	Maintains	Strong Buy	$220.00 → $245.00 +25.00 (11.4%)
Mar 21, 2026	Myles Minter	William Blair	Reiterates	Buy	-
Mar 13, 2026	Graig Suvannavejh	Mizuho	Maintains	Buy	-
Mar 13, 2026	Leonid Timashev	RBC Capital	Maintains	Buy	$222.00
Feb 25, 2026	Pete Stavropoulos	Cantor Fitzgerald	Maintains	Buy	$153.00 → $220.00 +67.00 (43.8%)
Feb 25, 2026	Ashwani Verma	UBS	Maintains	Buy	$248.00 → $251.00 +3.00 (1.2%)
Feb 24, 2026	PerPlexity Biotechnology	TipRanks - PerPlexity	Downgrades	Buy	$177.00 → $192.00 +15.00 (8.5%)
Feb 24, 2026	Anthropic Biotechnology	TipRanks - Anthropic	Reiterates	Hold	$170.00 → $179.00 +9.00 (5.3%)
Feb 24, 2026	OpenAI Biotechnology	TipRanks - OpenAI	Reiterates	Hold	$172.00 → $177.00 +5.00 (2.9%)
Feb 24, 2026	Yatin Suneja	Guggenheim	Maintains	Strong Buy	$205.00 → $220.00 +15.00 (7.3%)
Feb 24, 2026	Joon Lee	Truist	Maintains	Buy	-
Feb 24, 2026	Ashwani Verma	UBS	Maintains	Strong Buy	$248.00 → $251.00 +3.00 (1.2%)
Feb 24, 2026	Benjamin Burnett	Wells Fargo	Maintains	Buy	$193.00 → $202.00 +9.00 (4.7%)
Feb 24, 2026	Rudy Li	Wolfe Research	Initiates	Buy	$230.00
Feb 24, 2026	Leonid Timashev	RBC Capital	Maintains	Buy	$219.00 → $222.00 +3.00 (1.4%)
Feb 24, 2026	Sean Laaman	Morgan Stanley	Maintains	Hold	$204.00 → $207.00 +3.00 (1.5%)
Feb 23, 2026	Edmund Ingham	Forbes	Initiates Coverage	Sell	-
Feb 23, 2026	Yatin Suneja	Guggenheim	Maintains	Buy	$205.00 → $220.00 +15.00 (7.3%)
Feb 23, 2026	Myles Minter	William Blair	Maintains	Buy	-
Feb 23, 2026	Joseph Thome	TD Cowen	Maintains	Buy	$195.00 → $215.00 +20.00 (10.3%)
Feb 23, 2026	Jason Gerberry	BofA Securities	Reiterates	Buy	$178.00 → $214.00 +36.00 (20.2%)
Feb 23, 2026	Rudy Li	Wolfe Research	Initiates	Buy	$230.00
Feb 23, 2026	Ami Fadia	Needham	Reiterates	Strong Buy	$225.00 → $225.00 +0.00 (0.0%)
Feb 23, 2026	Leonid Timashev	RBC Capital	Maintains	Buy	$219.00 → $222.00 +3.00 (1.4%)
Feb 3, 2026	Andrew Tsai	Jefferies	Maintains	Strong Buy	$200.00 → $245.00 +45.00 (22.5%)
Jan 28, 2026	Marc Goodman	Leerink Partners	Maintains	Buy	$150.00 → $205.00 +55.00 (36.7%)
Jan 21, 2026	Leonid Timashev	RBC Capital	Maintains	Buy	$212.00 → $219.00 +7.00 (3.3%)
Jan 20, 2026	Raghuram Selvaraju	HC Wainwright	Maintains	Strong Buy	$200.00 → $260.00 +60.00 (30.0%)
Jan 16, 2026	David Amsellem	Piper Sandler	Maintains	Buy	$148.00 → $223.00 +75.00 (50.7%)
Jan 13, 2026	Benjamin Burnett	Wells Fargo	Maintains	Buy	$157.00 → $193.00 +36.00 (22.9%)
Jan 13, 2026	Brian Skorney	Baird	Maintains	Buy	$157.00 → $209.00 +52.00 (33.1%)
Jan 12, 2026	Google Biotechnology	TipRanks - Google	Reiterates	Buy	$165.00 → $190.00 +25.00 (15.2%)
Jan 12, 2026	PerPlexity Biotechnology	TipRanks - PerPlexity	Reiterates	Hold	$156.00 → $177.00 +21.00 (13.5%)
Jan 12, 2026	Anthropic Biotechnology	TipRanks - Anthropic	Reiterates	Hold	$150.00 → $170.00 +20.00 (13.3%)
Jan 12, 2026	DeepSeek Biotechnology	TipRanks - DeepSeek	Reiterates	Hold	$153.00 → $176.00 +23.00 (15.0%)
Jan 12, 2026	xAi Biotechnology	TipRanks - xAI	Reiterates	Hold	$149.00 → $171.00 +22.00 (14.8%)
Jan 12, 2026	OpenAI Biotechnology	TipRanks - OpenAI	Reiterates	Hold	$150.00 → $172.00 +22.00 (14.7%)
Jan 8, 2026	Sean Laaman	Morgan Stanley	Downgrades	Hold	$196.00 → $204.00 +8.00 (4.1%)
Jan 6, 2026	Ashwani Verma	UBS	Maintains	Strong Buy	$163.00 → $248.00 +85.00 (52.1%)
Jan 5, 2026	Raghuram Selvaraju	HC Wainwright	Maintains	Strong Buy	$185.00 → $200.00 +15.00 (8.1%)

Yatin Suneja

Guggenheim

Strong BuyMaintains

$220.00 → $245.00

Mar 25

Myles Minter

William Blair

BuyReiterates

Mar 21

Graig Suvannavejh

Mizuho

BuyMaintains

Mar 13

Leonid Timashev

RBC Capital

BuyMaintains

$222.00

Mar 13

Pete Stavropoulos

Cantor Fitzgerald

BuyMaintains

$153.00 → $220.00

Feb 25

Ashwani Verma

UBS

BuyMaintains

$248.00 → $251.00

Feb 25

PerPlexity Biotechnology

TipRanks - PerPlexity

BuyDowngrades

$177.00 → $192.00

Feb 24

Anthropic Biotechnology

TipRanks - Anthropic

HoldReiterates

$170.00 → $179.00

Feb 24

OpenAI Biotechnology

TipRanks - OpenAI

HoldReiterates

$172.00 → $177.00

Feb 24

Yatin Suneja

Guggenheim

Strong BuyMaintains

$205.00 → $220.00

Feb 24

Joon Lee

Truist

BuyMaintains

Feb 24

Ashwani Verma

UBS

Strong BuyMaintains

$248.00 → $251.00

Feb 24

Benjamin Burnett

Wells Fargo

BuyMaintains

$193.00 → $202.00

Feb 24

Rudy Li

Wolfe Research

BuyInitiates

$230.00

Feb 24

Leonid Timashev

RBC Capital

BuyMaintains

$219.00 → $222.00

Feb 24

Sean Laaman

Morgan Stanley

HoldMaintains

$204.00 → $207.00

Feb 24

Edmund Ingham

Forbes

SellInitiates Coverage

Feb 23

Yatin Suneja

Guggenheim

BuyMaintains

$205.00 → $220.00

Feb 23

Myles Minter

William Blair

BuyMaintains

Feb 23

Joseph Thome

TD Cowen

BuyMaintains

$195.00 → $215.00

Feb 23

Jason Gerberry

BofA Securities

BuyReiterates

$178.00 → $214.00

Feb 23

Rudy Li

Wolfe Research

BuyInitiates

$230.00

Feb 23

Ami Fadia

Needham

Strong BuyReiterates

$225.00 → $225.00

Feb 23

Leonid Timashev

RBC Capital

BuyMaintains

$219.00 → $222.00

Feb 23

Andrew Tsai

Jefferies

Strong BuyMaintains

$200.00 → $245.00

Feb 3

Marc Goodman

Leerink Partners

BuyMaintains

$150.00 → $205.00

Jan 28

Leonid Timashev

RBC Capital

BuyMaintains

$212.00 → $219.00

Jan 21

Raghuram Selvaraju

HC Wainwright

Strong BuyMaintains

$200.00 → $260.00

Jan 20

David Amsellem

Piper Sandler

BuyMaintains

$148.00 → $223.00

Jan 16

Benjamin Burnett

Wells Fargo

BuyMaintains

$157.00 → $193.00

Jan 13

Brian Skorney

Baird

BuyMaintains

$157.00 → $209.00

Jan 13

Google Biotechnology

TipRanks - Google

BuyReiterates

$165.00 → $190.00

Jan 12

PerPlexity Biotechnology

TipRanks - PerPlexity

HoldReiterates

$156.00 → $177.00

Jan 12

Anthropic Biotechnology

TipRanks - Anthropic

HoldReiterates

$150.00 → $170.00

Jan 12

DeepSeek Biotechnology

TipRanks - DeepSeek

HoldReiterates

$153.00 → $176.00

Jan 12

xAi Biotechnology

TipRanks - xAI

HoldReiterates

$149.00 → $171.00

Jan 12

OpenAI Biotechnology

TipRanks - OpenAI

HoldReiterates

$150.00 → $172.00

Jan 12

Sean Laaman

Morgan Stanley

HoldDowngrades

$196.00 → $204.00

Jan 8

Ashwani Verma

UBS

Strong BuyMaintains

$163.00 → $248.00

Jan 6

Raghuram Selvaraju

HC Wainwright

Strong BuyMaintains

$185.00 → $200.00

Jan 5

Axsome Therapeutics, Inc. (AXSM) Analyst Forecast

Analyst Consensus Rating

Consensus Rating

Average Price Target

Latest AXSM Analyst Ratings & Recommendations

Frequently Asked Questions